...
首页> 外文期刊>Allergy, Asthma & Immunology Research >The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 1. Definition, Methodology and First-line Management
【24h】

The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 1. Definition, Methodology and First-line Management

机译:Kaaaci / KDA基于韩国成年人慢性自发性荨麻疹的实践指南:第1部分。定义,方法和一线管理

获取原文

摘要

Chronic spontaneous urticaria (CSU) is defined as the occurrence of spontaneous wheals, angioedema, or both for 6 weeks in the absence of specific causes. It is a common condition associated with substantial disease burden both for affected individuals and societies in many countries, including Korea. CSU frequently persists for several years and requires high-intensity treatment; therefore, patients experience deteriorations in quality of life and medication-associated complications. During the last decade, there have been major advances in the pharmacological treatment of CSU and there is an outstanding need for evidence-based guidelines that reflect clinical practice in Korea. The guidelines reported here represent a joint initiative of the Korean Academy of Asthma, Allergy and Clinical Immunology and the Korean Dermatological Association, and aim to provide evidence-based guidance for the management of CSU in Korean adults and children. In Part 1, disease definition, guideline scope and development methodology as well as evidence-based recommendations on the use of antihistamines and corticosteroids are summarized.Copyright ? 2020 The Korean Academy of Asthma, Allergy and Clinical Immunology · The Korean Academy of Pediatric Allergy and Respiratory Disease.
机译:慢性自发性荨麻疹(CSU)被定义为在没有特定原因的情况下被定义为自发性扭矩,血管内膜或两者的发生。在包括韩国在内的许多国家的受影响的个人和社会,这是一种常见的疾病,这对于受影响的个人和社会来说有关。 CSU经常持续多年,需要高强度治疗;因此,患者体验生活质量和药物相关并发症的恶化。在过去的十年中,CSU的药理治疗有重大进展,并有一个突出的基于证据的准则,反映了韩国的临床实践。此处报告的指南代表了韩国哮喘,过敏和临床免疫学和韩国皮肤病学会的联合倡议,并旨在为韩国成年人和儿童管理CSU的管理提供证据。在第1部分,综述了关于使用抗组胺药和皮质类固醇的疾病定义,指南范围和开发方法以及基于证据的建议.Copyright? 2020韩国哮喘学院,过敏和临床免疫学·韩国儿科过敏和呼吸系统院。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号